Sartorius Stedim Biotech Investor Relations Service

Half-Year Results 2014

Half-Year Report January to June 2014 (228 KB)

Presentation on half-year results 2014

Download Presentation (993 KB)

News

Miriam Monge to Join Sartorius Stedim Biotech as Director

Aubagne, August 26, 2014 – Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, today announced the appointment of Miriam Monge as Director of Marketing for SSB’s...[more]

Date: 26.08.2014     Category: Sartorius Stedim Biotech

First half of 2014: Sartorius Stedim Biotech continues dynamic growth

in € million unless otherwise specified1st half 20141st half 2013Growth in %Growth in %const. fx Order intake338.4311.58.710.7Sales revenue324.1292.610.812.7  ...[more]

Date: 22.07.2014     Category: Sartorius Stedim Biotech

Sartorius Stedim Biotech Share (DIM)

Petra Kirchhoff

Vice President of Corporate Communications & Investor Relations

petra.kirchhoff
(at)sartorius.com
Phone: +49 551 308-1686

Andreas Theisen

Director Investor Relations

andreas.theisen
(at)sartorius.com

Phone: +49 551 308-1668